• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测甲状腺乳头状癌侧方淋巴结转移的CUNR评分系统。

CUNR scoring system for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma.

作者信息

Lei Jianyong, Li Gengpeng, Li Zhihui, Rong R X, Zhu Jingqiang

机构信息

Thyroid and Parathyroid Surgery Center, West China Hospital of Sichuan University, Chengdu 610041, China.

出版信息

Oncotarget. 2017 Nov 30;9(1):167-177. doi: 10.18632/oncotarget.22772. eCollection 2018 Jan 2.

DOI:10.18632/oncotarget.22772
PMID:29416604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787454/
Abstract

OBJECTIVE

Our present study aimed to evaluate and compare the number and rate of central lymph node metastases (LNMs) for the prediction of lateral LNM (LLNM) in papillary thyroid carcinoma (PTC) and to develop a scoring system.

RESULTS

Capsule invasion, tumor location in the upper portion of the thyroid, an ipsilateral central compartment LNM number ≥3, and an ipsilateral central compartment LNM rate of ≥56% were identified as significant independent predictors of ipsilateral lateral LNM in PTC. The predictive ability of an ipsilateral central compartment LNM rate ≥56% (area under the curve (AUC) = 0.802) was better than that of an ipsilateral central compartment LNM number ≥3 (AUC = 0.755). The ROC curves identified the best index point (CUNR) to distinguish the presence or absence of ipsilateral LLNM as 11, which has a high sensitivity (0.860) and a low false-negative rate (0.100, 1-Specificity). These findings were supported by the validation cohort.

CONCLUSIONS

Patients with a CUNR index point equal to or greater than 11 and ipsilateral lateral lymph node dissection should be considered for a diagnosis of LLNM.

PATIENTS AND METHODS

A total of 1,281 PTC patients were included and divided into two groups: those with a presence of LLNM ( = 222) and those with an absence of LLNM ( = 1059). Univariate and multivariate analyses were performed to detect the risk factors for LLNM, and receiver operating characteristic (ROC) curves were used to detect the best cutoff values of these predictors. Additionally, a scoring system for the odds ratio (OR) of independent factors was developed and validated in an independent cohort of PTC patients ( = 560).

摘要

目的

本研究旨在评估和比较甲状腺乳头状癌(PTC)中央区淋巴结转移(LNM)的数量和发生率,以预测侧方淋巴结转移(LLNM),并建立一个评分系统。

结果

被膜侵犯、肿瘤位于甲状腺上部、同侧中央区LNM数量≥3以及同侧中央区LNM发生率≥56%被确定为PTC同侧LLNM的重要独立预测因素。同侧中央区LNM发生率≥56%(曲线下面积(AUC)=0.802)的预测能力优于同侧中央区LNM数量≥3(AUC = 0.755)。ROC曲线确定区分同侧LLNM有无的最佳指标点(CUNR)为11,其具有高敏感性(0.860)和低假阴性率(0.100,1-特异性)。这些发现得到了验证队列的支持。

结论

CUNR指标点等于或大于11且进行同侧侧方淋巴结清扫的患者应考虑诊断为LLNM。

患者和方法

共纳入1281例PTC患者,分为两组:有LLNM的患者(=222例)和无LLNM的患者(=1059例)。进行单因素和多因素分析以检测LLNM的危险因素,并使用受试者工作特征(ROC)曲线检测这些预测因素的最佳截断值。此外,还开发了一个独立因素比值比(OR)的评分系统,并在一个独立的PTC患者队列(=560例)中进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/9c9a75d82c26/oncotarget-09-167-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/7ec5354497cf/oncotarget-09-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/c1f5781a0001/oncotarget-09-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/e8f004458abe/oncotarget-09-167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/8e8b4986bab8/oncotarget-09-167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/5d0a28cae942/oncotarget-09-167-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/bc1c34d1da4f/oncotarget-09-167-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/9c9a75d82c26/oncotarget-09-167-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/7ec5354497cf/oncotarget-09-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/c1f5781a0001/oncotarget-09-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/e8f004458abe/oncotarget-09-167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/8e8b4986bab8/oncotarget-09-167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/5d0a28cae942/oncotarget-09-167-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/bc1c34d1da4f/oncotarget-09-167-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e9/5787454/9c9a75d82c26/oncotarget-09-167-g006.jpg

相似文献

1
CUNR scoring system for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma.用于预测甲状腺乳头状癌侧方淋巴结转移的CUNR评分系统。
Oncotarget. 2017 Nov 30;9(1):167-177. doi: 10.18632/oncotarget.22772. eCollection 2018 Jan 2.
2
Optimal range of lymph node dissection in patients with unilateral papillary thyroid carcinoma with lateral cervical lymph node metastasis.单侧甲状腺乳头状癌伴侧颈淋巴结转移患者淋巴结清扫的最佳范围
Front Oncol. 2023 Dec 14;13:1307937. doi: 10.3389/fonc.2023.1307937. eCollection 2023.
3
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
4
Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.预测甲状腺乳头状癌同侧颈侧区淋巴结转移:一项联合双能 CT 和甲状腺功能指标的研究。
BMC Cancer. 2021 Mar 4;21(1):221. doi: 10.1186/s12885-021-07951-0.
5
Development and validation of web-based nomograms for predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma.用于预测甲状腺乳头状癌患者侧方淋巴结转移的基于网络的列线图的开发与验证
Gland Surg. 2020 Apr;9(2):172-182. doi: 10.21037/gs.2020.01.11.
6
Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size.预测甲状腺乳头状癌侧方淋巴结转移的列线图:按大小分层
Front Oncol. 2022 Sep 28;12:944414. doi: 10.3389/fonc.2022.944414. eCollection 2022.
7
Features of Lymph Node Metastasis and Structural Recurrence in Papillary Thyroid Carcinoma Located in the Upper Portion of the Thyroid: A Retrospective Cohort Study.甲状腺上部的甲状腺乳头状癌的淋巴结转移和结构复发的特征:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Jan 25;12:793997. doi: 10.3389/fendo.2021.793997. eCollection 2021.
8
Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.临床存在侧方淋巴结转移的孤立性乳头状甲状腺癌发生Ⅴ级淋巴结转移的危险因素
Cancer Med. 2016 Aug;5(8):2161-8. doi: 10.1002/cam4.792. Epub 2016 Jul 1.
9
A prediction model incorporating the BRAF protein status for determining the risk of cervical lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis.一种纳入BRAF蛋白状态的预测模型,用于确定伴有中央淋巴结转移的甲状腺乳头状癌患者发生颈侧方淋巴结转移的风险。
Eur J Surg Oncol. 2021 Nov;47(11):2774-2780. doi: 10.1016/j.ejso.2021.08.033. Epub 2021 Aug 27.
10
Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with Mutation and Clinicopathological Features.具有突变及临床病理特征的甲状腺乳头状癌Ⅴ区淋巴结转移的预测因素
Cancer Manag Res. 2020 May 13;12:3371-3378. doi: 10.2147/CMAR.S247914. eCollection 2020.

引用本文的文献

1
Development and validation of web-based nomograms for predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma.用于预测甲状腺乳头状癌患者侧方淋巴结转移的基于网络的列线图的开发与验证
Gland Surg. 2020 Apr;9(2):172-182. doi: 10.21037/gs.2020.01.11.

本文引用的文献

1
Overview of the 8th Edition TNM Classification for Head and Neck Cancer.第八版头颈部癌TNM分类概述。
Curr Treat Options Oncol. 2017 Jul;18(7):40. doi: 10.1007/s11864-017-0484-y.
2
Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection.行改良根治性颈清扫术的甲状腺乳头癌患者复发的风险因素。
Br J Surg. 2016 Jul;103(8):1020-5. doi: 10.1002/bjs.10144. Epub 2016 Apr 28.
3
Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌淋巴结转移的预测因素
Ann Surg Oncol. 2016 Sep;23(9):2866-73. doi: 10.1245/s10434-016-5225-0. Epub 2016 Apr 13.
4
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
5
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
6
The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.在伴有或不伴有桥本甲状腺炎的乳头状甲状腺癌中,中央淋巴结转移在预测侧方淋巴结转移及预后方面的临床病理差异。
Tumour Biol. 2016 Jun;37(6):8037-45. doi: 10.1007/s13277-015-4706-2. Epub 2015 Dec 28.
7
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
8
Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study.单侧甲状腺乳头状癌同侧及对侧中央淋巴结转移的预测:一项回顾性研究
Gland Surg. 2015 Aug;4(4):288-94. doi: 10.3978/j.issn.2227-684X.2015.05.06.
9
A Meta-analysis of Central Lymph Node Metastasis for Predicting Lateral Involvement in Papillary Thyroid Carcinoma.一项关于中央淋巴结转移预测甲状腺乳头状癌侧方受累的Meta分析。
Otolaryngol Head Neck Surg. 2015 Nov;153(5):731-8. doi: 10.1177/0194599815601412. Epub 2015 Aug 25.
10
Papillary thyroid microcarcinomas located at the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasis.位于甲状腺中三分之一中部的甲状腺微小乳头状癌与颈部转移的存在相关。
Surgery. 2015 Mar;157(3):526-33. doi: 10.1016/j.surg.2014.10.020. Epub 2014 Nov 27.